Google now appears to be working on individual toggles, letting you back up or exclude specific apps. The list sorts apps by ...

For reference, NotebookLM currently lets you import information from links (YouTube and general websites), alongside copied text, and even Google Docs and Slides saved in your Google Drive. These are ...

Samsung is reportedly working on a smart data saver feature for the upcoming One UI 8.5. It aims to save data while the user ...

GREEN BAY – The Packers have listed five questionable and ruled out two for Sunday night's matchup with the Pittsburgh Steelers. Defensive lineman Lukas Van Ness (knee) and receiver Dontayvion Wicks ...

Artificial Intelligence (AI) and High Performance Computer (HPC) mining stocks are rallying pre-market following news of the largest AI infrastructure financing on record, according to Bloomberg.

Artificial intelligence has developed rapidly in recent years, with tech companies investing billions of dollars in data centers to help train and run AI models. The expansion of data centers has ...

A few days ago, Apple published documentation for a new framework designed to simplify the transfer of third-party app data between iOS and Android. Here’s how it’ll work. AppMigrationKit to allow ‘a ...

There was a special guest Monday at Celtics practice and his presence could pay major dividends for a team seeking an identity and to positively navigate a difficult early-season schedule. Despite New ...

An aerial view of the first QTS Data Center building under construction in southwest Cedar Rapids in August 2025. This building is along 76th St. SW and is the first of several buildings that will be ...

Enzalutamide plus leuprolide significantly improves overall survival and metastasis-free survival in biochemically recurrent prostate cancer compared to leuprolide alone. Subgroup analysis revealed ...

Nivolumab significantly improves DFS, OS, and DSS in high-risk muscle-invasive urothelial carcinoma, especially in patients with PD-L1 expression ≥1%. The study's 5-year follow-up confirms nivolumab's ...